In comparison with the control group, we observed a significant increase in the mRNA levels of Bax and caspase-3, along with a decrease in Bcl-2 mRNA level in GCs from the PCOS group (Fig 3A). The gene discussed is CASP3; the disease is polycystic ovary syndrome.